Jack Lenox, MD
Gynecology · Rockford, ILNPI 1508979345
Payments from drug & device makers
What this record shows
This record is dominated by education: $156,099 of the $207,885 with a category attached, or 75.1%. Intuitive Surgical accounts for 80.2% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2021 at $94,278 and has fallen 87.0% since, to $12,275 in 2025. Among gynecology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $664.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$167K
- AbbVie$39K
- Astellas Pharma US Inc$260
- Coopersurgical, Inc.$216
- Therapeuticsmd, Inc.$202
- Myovant Sciences Inc.$195
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$32,52516%
- Travel & lodging$7,2253%
- Food & beverage$12,0366%
- Education$156,09975%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 125 | $166,622 |
| AbbVie | 88 | $38,788 |
| Astellas Pharma US Inc | 9 | $260 |
| Coopersurgical, Inc. | 5 | $216 |
| Therapeuticsmd, Inc. | 13 | $202 |
| Myovant Sciences Inc. | 7 | $195 |
| Hologic Sales And Service, LLC | 4 | $188 |
| Gynesonics, Inc. | 3 | $156 |
| Pfizer | 9 | $153 |
| Exeltis, USA Inc. | 7 | $128 |
| Baxter Healthcare | 1 | $107 |
| Agile Therapeutics, Inc. | 5 | $101 |
| Novo Nordisk | 4 | $76 |
| Aspira Women's Health Inc | 2 | $73 |
| Organon | 4 | $73 |
| Merck | 4 | $72 |
| Biohaven Pharmaceuticals, Inc. | 3 | $72 |
| Avion Pharmaceuticals | 4 | $67 |
| Amgen | 4 | $66 |
| Smith+Nephew | 2 | $57 |
| Arteriocyte Medical Systems, Inc. | 1 | $43 |
| Conmed Corporation | 1 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Minerva Surgical, Inc | 2 | $29 |
| Channel Medsystems, Inc. | 1 | $21 |
| Bayer | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$207,885 in reported general payments places this provider in the 95th percentile of 68 gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 19 | $12,769 |
| VeozahFezolinetant | 11 | $9,247 |
| Estradiol | 54 | $5,373 |
| Estradiol (Once Weekly)Estradiol | 45 | $4,218 |
| Estradiol (Twice Weekly)Estradiol | 27 | $2,851 |
| ProgesteroneProgesterone, Micronized | 36 | $1,685 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq, Veozah | $260 | $22,01630 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 68 gynecology providers in Illinois.
Other gynecology in Rockford
- Nicole WilliamsChicago$527K
- Nahla MerhiNew Lenox$492K
- Pierre JohnsonDecatur$360K
- Lauren StreicherChicago$48K
- Monica MooreChicago$29K
- Catherine BrankinChicago$22K
- Frank TuSkokie$21K
- Obianuju Madueke-LaveauxChicago$15K
- Haleema SadathBloomingdale$11K
- Sangeeta SenapatiSkokie$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.